This thesis regards treatment effects in patients with chronic hepatitis B and C, and focuses on the tools that are used to analyse these effects. In this introduction the clinical background of hepatitis B and C along with the current treatment options are described. Clinical questions arisen from the effects of treatment are stated and the current state of art of statistical models to study these effects is provided.

, , , , ,
FSC Mix, Erasmus MC Rotterdam, Novartis Pharma B.V., Roche Nederland B.V., Schering Plough Nederland, Zambon Nederland B.V.
H.L.A. Janssen (Harry)
Erasmus University Rotterdam
hdl.handle.net/1765/21396
Erasmus MC: University Medical Center Rotterdam

Hansen, B. (2010, November 19). Statistical Models of Treatment Effects in Chronic Hepatitis B and C. Retrieved from http://hdl.handle.net/1765/21396